CoChat

Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease

Karami, Azadeh, Eyjolfsdottir, Helga, Vijayaraghavan, Swetha, Lind, Göran, Almqvist, Per, Kadir, Ahmadul, Linderoth, Bengt, Andreasen, Niels, Blennow, Kaj, Wall, Anders, Westman, Eric, Ferreira, Daniel, Kristoffersen Wiberg, Maria, Wahlund, Lars‐Olof, Seiger, Åke, Nordberg, Agneta, Wahlberg, Lars, Darreh‐Shori, Taher, Eriksdotter, Maria · 2015 · Alzheimer's & Dementia
Cited by 63

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Introduction: The extensive loss of central cholinergic functions in Alzheimer's disease (AD) brain is linked to impaired nerve growth factor (NGF) signaling. The cardinal cholinergic biomarker is the acetylcholine synthesizing enzyme, choline acetyltransferase (ChAT), which has recently been found in cerebrospinal fluid (CSF). The purpose of this study was to see if EC‐NGF therapy will alter CSF levels of cholinergic biomarkers, ChAT, and acetylcholinesterase. Method: Encapsulated cell implants releasing NGF (EC‐NGF) were surgically implanted bilaterally in the basal forebrain of six AD patients for 12 months and cholinergic markers in CSF were analyzed. Results: Activities of both enzymes were altered after 12 months. In particular, the activity of soluble ChAT showed high correlation with cognition, CSF tau and amyloid‐β, in vivo cerebral glucose utilization and nicotinic binding sites, and morphometric and volumetric magnetic resonance imaging measures. Discussion: A clear pattern of association is demonstrated showing a proof‐of‐principle effect on CSF cholinergic markers, suggestive of a beneficial EC‐NGF implant therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2014.11.008

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 63

Metadata

Authors
Karami, A., Eyjolfsdottir, H., Vijayaraghavan, S., Lind, G., Almqvist, P., Kadir, A., Linderoth, B., Andreasen, N., Blennow, K., Wall, A., Westman, E., Ferreira, D., Kristoffersen Wiberg, M., Wahlund, L., Seiger, Å., Nordberg, A., Wahlberg, L., Darreh‐Shori, T., & Eriksdotter, M.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2015-02-09
Volume
11
Issue
11
Pages
1316-1328
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2081599094
Cited by
63
References
4
FWCI
4.52
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.jalz.2014.11.008
The paper
Karami, A., Eyjolfsdottir, H., Vijayaraghavan, S., Lind, G., Almqvist, P., Kadir, A., Linderoth, B., Andreasen, N., Blennow, K., Wall, A., Westman, E., Ferreira, D., Kristoffersen Wiberg, M., Wahlund, L., Seiger, Å., Nordberg, A., Wahlberg, L., Darreh‐Shori, T., & Eriksdotter, M. (2015). Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2014.11.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.